logo-loader
viewFeedback PLC

Full interview: Feedback hails new fluoroscopy technology

Feedback (LON:FDBK) specialises in medical imaging technology, such as magnetic resonance imaging (MRI) scans and X-Rays.
CEO Tom Oakley is a radiologist and understands the niche gaps in the medical imaging market and here he tells Proactive London how he's building a new revenue stream on the back of software already developed.
Oakley explains how his company is rolling out the new fluoroscopy technique, which is basically a x-ray movie, across 200 sites in the US 
and how it doesn't mean expensive new kit for users.
Updates here too on Feedback's flagship Bleepa product, the encrypted medical messaging app used on smartphones, tablets and desktops, allowing clinicians to communicate with other team members securely.

Quick facts: Feedback PLC

Price: 0.55 GBX

LSE:FDBK
Market: LSE
Market Cap: £2.97 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Feedback PLC named herein, including the promotion by the Company of Feedback PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Feedback PLC 'on the right trajectory' as it looks to...

Feedback PLC's (LON:FDBK) CEO Tom Oakley speaks to Proactive London's Andrew Scott soon after the release of its interim results to November 2019. Oakley says the big focus for them currently is to convert the results of a pilot study of its new app Bleepa for doctors into “meaningful...

on 26/2/20

2 min read